Cyclic dinucleotides useful for the treatment of inter alia cancer
US10047115B2 · kind B2 · utility
11Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2016 |
| Grant date | Aug 14, 2018 |
| Priority date | — |
| Expiry date | Jan 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/213
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I) or a pharmaceutically acceptable salt and tautomers thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, in the treatment of diseases and conditions in which modulation of STING (Stimulator of Interferon Genes) is beneficial, for example inflammation, allergic and autoimmune diseases, infectious diseases, cancer, pre-cancerous syndromes and as vaccine adjuvants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.